1.Mechanisms of Immune Evasion in the Dual Tumor Microenvironment of Ovarian Cancer and Targeted Therapeutic Strategies
Karima ABDUGHENI· ; Junxiu LIU
Journal of Sun Yat-sen University(Medical Sciences) 2026;47(5):767-779
Epithelial ovarian cancer (EOC), particularly high-grade serous ovarian cancer (HGSOC), commonly presents with intraperitoneal dissemination, peritoneal implants, and malignant ascites. The objective response rate to immune checkpoint inhibitor (ICI) monotherapy is approximately 8%-15%. A key underlying reason is that the distinctive intraperitoneal spread of EOC places tumor cells simultaneously within both a “solid” microenvironment (formed by solid lesions/peritoneal implants) and a “liquid” microenvironment (represented by malignant ascites); these two compartments continuously interact through cellular trafficking, exosome-mediated transfer, cytokine diffusion, and lipid metabolic exchange, collectively shaping the typical “cold tumor” phenotype. Centered on this solid-liquid dual microenvironment, this review dissects, at the cellular level, the immunosuppressive network established by M2-polarized tumor-associated macrophages, enriched regulatory T cells, expanded myeloid-derived suppressor cells, and dysfunctional dendritic/NK and CD8+ T cells; and elucidates, at the molecular level, the central roles of IL-4/IL-6/TGF-β/VEGF cytokine axis imbalance, lipid metabolic reprogramming, lactate accumulation, and impaired antigen presentation in driving T-cell exhaustion and platinum resistance. On the therapeutic front, integrating the latest evidence from KEYNOTE-B96, DUO-O, FIRST/ENGOT-OV44, ATHENA-COMBO, MIRASOL, OVHIPEC-1 and PIPAC studies, this review summarizes the evidence supporting immune-combination regimens, anti-angiogenic agents, folate receptor alpha antibody-drug conjugates, hyperthermic intraperitoneal chemotherapy, and local intraperitoneal delivery from the dual perspectives of systemic immune modulation and local microenvironment intervention. The dual-microenvironment framework may help explain the poor response to immunotherapy and inform rational combination strategies in EOC; however, clinical translation should be based on precise stratification according to histology, BRCA/homologous recombination deficiency status, PD-L1 and folate receptor alpha expression, and spatial immune phenotypes.
2.Research Progress on Microglia Heterogeneity and Their Role in Multiple Sclerosis
Journal of Sun Yat-sen University(Medical Sciences) 2026;47(5):780-787
Multiple sclerosis (MS) is a chronic immune-mediated demyelinating disease of the central nervous system. As the resident innate immune cells of the CNS, microglia exert dual regulatory effects throughout the disease course, encompassing both detrimental and reparative functions. Numerous studies have confirmed that microglia exhibit significant heterogeneity across development, aging, and pathological states, and multiple subpopulations have been identified, including proliferative region-associated microglia, disease-associated microglia, interferon-responsive microglia, and microglia inflamed in MS. This review summarizes the current state of microglial heterogeneity research and its implications in MS, with a particular focus on the mechanisms underlying their regulation of neuroinflammation and remyelination. It provides a theoretical reference for precision therapies targeting microglial subpopulations and offers novel insights for the clinical management of MS.
3.Research Progress on the Regulation of Chronic Metabolic Diseases by Paracrine Fibroblast Growth Factors
Journal of Sun Yat-sen University(Medical Sciences) 2026;47(5):788-798
The incidence of chronic metabolic diseases, including obesity, type 2 diabetes mellitus (T2DM) and metabolic dysfunction-associated steatotic liver disease (MASLD), continues to rise globally. Disordered glucose and lipid metabolism represents their common pathophysiological foundation. Secreted fibroblast growth factor (FGF) is key regulators of glucose and lipid homeostasis. Among them, the paracrine FGFs, mainly comprising FGF1, FGF2, FGF4, FGF6, FGF8, FGF9, FGF10, and FGF16, require systematic integration regarding their metabolic regulatory functions. This review elucidates the molecular structural characteristics of paracrine FGFs and their central regulatory roles in maintaining glucose and lipid homeostasis, covering their modulation of metabolic networks over multiple tissues and organs including, adipose tissue, liver, skeletal muscle, pancreatic islets, and the nervous system. Furthermore, the expression alterations and functional abnormalities of these factors in chronic metabolic diseases are summarized. This review aims to highlight the critical position of paracrine FGFs in the pathogenesis of metabolic diseases and to provide novel therapeutic targets and theoretical foundations for the prevention and treatment of disorders associated with glucolipid metabolic dysregulation.
4.Progress in Integrin Targeted Radionuclide Therapy
Journal of Sun Yat-sen University(Medical Sciences) 2026;47(5):799-808
Integrin αvβ3 is an important target for tumor imaging and therapy. It is highly expressed on tumor neovascular endothelial cells and various malignant tumor cells, while being nearly absent in normal tissues and quiescent endothelial cells. Positron emission tomography (PET) based on Arg-Gly-Asp (RGD) peptides has been widely applied, yet single-target strategies are limited by tumor heterogeneity. β- radionuclide-labeled RGD peptides exhibit problems of insufficient tumor uptake and renal accumulation. This review summarizes the preclinical progress in two frontier directions. Dual-targeting strategies combine integrin αvβ3 with prostate-specific membrane antigen (PSMA) or fibroblast activation protein (FAP) to construct heterodimeric probes. Preclinical and clinical studies have demonstrated that dual-targeting probes achieve significantly superior tumor uptake, target-to-background ratios, and lesion detection rates compared to single-target controls, effectively overcoming tumor heterogeneity and improving tumor uptake and detection rate. α radionuclides, by leveraging high linear energy transfer and short tissue range, demonstrate superior antitumor efficacy over β-radionuclides. In terms of clinical translation, the albumin-binding RGD dimer labeled with lutetium-177 (¹⁷⁷Lu-AB-3PRGD₂) has completed a first-in-human study, preliminarily validating the clinical feasibility of integrin-targeted radionuclide therapy, albeit with limited antitumor activity. Future directions include molecular imaging-based patient selection, optimization of dual-targeting molecular structures, and development of α radionuclide formulations.
5.Research Progress on Ferroptosis in the Pathogenesis of Neurodegenerative Diseases
Journal of Sun Yat-sen University(Medical Sciences) 2026;47(5):809-819
Driven by the global trend of population aging, the prevalence of neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS), has been rising consistently. The pathogenic mechanisms of these disorders are complex, and effective disease-modifying therapies remain an unmet clinical need. Ferroptosis, a regulated cell death modality driven by iron-dependent lipid peroxidation, has been widely implicated in the occurrence and evolution of the aforementioned conditions. Under pathological states, both perturbed iron metabolism and reactive oxygen species (ROS) accumulation can precipitate ferroptosis. Specifically, iron overload exacerbates oxidative injury via the Fenton reaction, disrupts the glutathione (GSH)-based antioxidant defense system, and induces extensive peroxidation of polyunsaturated fatty acids (PUFAs), ultimately culminating in neuronal damage. Furthermore, ferroptosis interacts synergistically with other pathological hallmarks, such as oxidative stress, neuroinflammation, aberrant protein aggregation, and apoptosis, thereby accelerating disease progression. A synthesis of current evidence indicates that disrupted iron homeostasis, enhanced lipid peroxidation, GSH depletion, and impaired glutathione peroxidase 4 (GPX4) activity constitute the common basis for ferroptosis in these neurodegenerative diseases. Concurrently, ferroptosis also displays certain disease‑specific characteristics by engaging distinct pathogenic proteins and regulatory pathways in each disorder. In this review, we delineate the molecular regulatory framework of ferroptosis, summarize its research progress in AD, PD, HD, and ALS, and highlight both shared mechanisms and divergent regulatory pathways across these diseases, with the goal of informing future investigations into disease pathogenesis and the discovery of novel strategies.
6.Bawei Chenxiang Wan Protects Against Acute Myocardial Ischemia by Activating Phosphatidylinositol 3-Kinase to Inhibit Cuproptosis in Rats
Xiaoying ZHANG ; Yuquan XIE ; Yuchan ZHANG ; Qi SI ; Yuanhu XIAO ; Yuqi GUO ; Xiayu SHAO
Journal of Sun Yat-sen University(Medical Sciences) 2026;47(5):820-832
ObjectiveTo investigate the protective effect and underlying mechanisms of the Bawei Chenxiang Wan (BCW) against myocardial ischemic injury. MethodsMyocardial ischemia in vivo was induced in rats by subcutaneous injection of isoproterenol (ISO), and ex vivo ischemia was established by coronary artery ligation in isolated rat hearts. The effects of BCW, alcohol extracts and its polar extracts were evaluated on ST segment on electrocardiogram (ECG), myocardial damage, hemodynamic parameters, and infarct size. The phosphorylation level of phosphatidylinositol 3-kinase (PI3K), the expression of cuproptosis-related proteins, and the content of Cu²⁺ in myocardial tissue were detected. The regulatory relationship of the signaling pathway was verified using an oxygen-glucose deprivation (OGD) myocardial cell injury model, combined with PI3K agonists and inhibitors. ResultsBCW ameliorated ST-segment elevation on electrocardiograms(P<0.01), reduced serum levels of myocardial injury markers, improved hemodynamic parameters, upregulated PI3K phosphorylation(P<0.01), and decreased Cu²⁺ accumulation in rats with myocardial ischemia(P<0.01). Moreover, BCW reduced the myocardial infarct size. In the isolated rat heart model of ischemia, both the ethanol extract and various solvent fractions of BCW exerted protective effects and reduced Cu²⁺ content, among which the n-butanol fraction exhibited the most potent activity(P<0.01). Specifically, the n-butanol fraction upregulated PI3K phosphorylation(P<0.01) and downregulated the expression of cuproptosis-related proteins, including ferredoxin reductase 1(FDX1)(P<0.05), lipoic acid synthetase(LIAS), and dihydrolipoamide S-acetyltransferase(DLAT) oligomerization(P<0.05). In the OGD-induced cardiomyocyte injury model, treatment with a PI3K agonist inhibited DLAT oligomerization(P<0.05), whereas co-administration of a PI3K inhibitor attenuated the inhibitory effect of the n-butanol fraction on DLAT oligomer formation(P<0.05). ConclusionThe n-butanol fraction of BCW exerts a significant protective effect against myocardial ischemic injury, and its mechanism may involve activation of the PI3K and inhibition of cuproptosis.
7.PAGE5 in Promoting Breast Cancer Invasion and Hepatic Metastasis via Regulation of the PI3K/AKT/MMP1 Axis
Zenghui LIU ; Ying LU ; Xiaoli LIANG ; Wanna CHEN ; Xiangdong XU ; Hongbiao XU ; Zhen SHAN
Journal of Sun Yat-sen University(Medical Sciences) 2026;47(5):833-842
ObjectiveThis study aimed to elucidate the specific molecular mechanism by which PAGE5 promotes breast cancer cell invasion and hepatic metastasis through regulating the PI3K/AKT signaling pathway and its downstream effector, matrix metalloproteinase 1 (MMP1). MethodsBioinformatics analysis using the TCGA database was performed to evaluate PAGE5 expression in metastatic breast cancer tissues. The effects of PAGE5 on the proliferation, migration, and invasion capabilities of breast cancer cells were analyzed using CCK-8, EdU, Transwell, and wound healing assays. A splenic injection hepatic metastasis model in NOD-SCID mice was employed to validate the impact of PAGE5 on breast cancer liver metastasis. Transcriptome sequencing and KEGG enrichment analysis were conducted to identify potential signaling pathways regulated by PAGE5. Western blot was used to detect AKT phosphorylation levels. Quantitative real-time polymerase chain reaction (qPCR) was applied to screen and validate downstream target molecules of PAGE5. ResultsBioinformatic analysis revealed that PAGE5 expression was significantly upregulated in distant metastasis of breast cancer. Both in vitro and in vivo experiments confirmed that PAGE5 overexpression markedly enhanced the migration and invasion abilities of breast cancer cells and promoted the formation of liver metastatic lesions, whereas PAGE5 knockdown suppressed breast cancer liver metastasis (P<0.000 1). Transcriptome sequencing and KEGG enrichment analysis indicated that PAGE5 significantly activated the PI3K-AKT signaling pathway (P=0.028 5). Western blot confirmed that PAGE5 upregulated p-AKT levels, which could be reversed by MK2206. The qPCR results confirmed that MMP1 is a key downstream effector of PAGE5, and its expression can be inhibited by MK2206 (P<0.000 1). ConclusionsThis study preliminarily demonstrates that PAGE5 can activate the PI3K/AKT signaling pathway and mediate the invasion and liver metastasis of breast cancer through MMP1.
8.Immunoregulatory Effects of Gallic Acid on BCG-infected Macrophages
Shumei HE ; Shuyi NI ; Mengyuan XU ; Qingxiao ZHAO
Journal of Sun Yat-sen University(Medical Sciences) 2026;47(5):843-856
ObjectiveTo explore the host immunomodulatory effect and its molecular mechanism of gallic acid (GA) in Bacillus Calmette-Guérin (BCG) infected macrophages, and to provide experimental evidence for host-directed anti-tuberculosis research against Mycobacterium tuberculosis (Mtb). MethodsThe minimum inhibitory concentration (MIC) of GA against BCG was determined by resazurin colorimetric assay. Bacterial growth-curve test and MTT colorimetric assay were used to evaluate the effects of GA on BCG proliferation and invasion. A BCG-infected RAW264.7 macrophage model was established, including infection control group (Ctrl), isoniazid (INH) group, and low-, medium- and high-dose GA groups. Flow cytometry combined with colony-plate counting was performed to detect intracellular BCG survival. Cell apoptosis was measured by Annexin V-APC/7-AAD double staining, and qRT-PCR was used to detect the mRNA expression of apoptosis-related genes Caspase-3 and Bcl-2. Macrophage polarization phenotypes were analyzed by flow cytometry. Intracellular reactive oxygen species (ROS) were detected using DHE fluorescent probe. The Griess assay was applied to determine supernatant nitric oxide (NO) concentration. ELISA was used to detect the levels of TNF-α, IFN-γ, IL-6 and IL-10 in cell culture supernatant. ResultsThe MIC of GA against BCG was 1 250 μmol/L. GA inhibited BCG proliferation and invasion in a concentration-dependent manner (P<0.05). Safe concentrations of 20, 40 and 80 μmol/L were selected for subsequent cellular experiments. Thirty-six-hour GA pretreatment markedly reduced the intracellular BCG bacterial load (P<0.05). GA exerted bidirectional regulation on macrophage apoptosis: it inhibited apoptosis at the early-stage infection and promoted apoptosis at the late-stage infection. GA induced M1-type polarization in early infection and facilitated M2-type polarization in late infection (P<0.05). Meanwhile, GA decreased intracellular ROS and NO levels, down-regulated the secretion of pro-inflammatory cytokines and up-regulated the secretion of anti-inflammatory cytokine IL-10 (P<0.05). ConclusionGA inhibits BCG proliferation and invasion in vitro. It remodels host immune microenvironment via bidirectional regulation of macrophage apoptosis and polarization as well as anti-oxidative and anti-inflammatory effects, showing potential value for host-directed anti-mycobacterial therapy.
9.Burden and Trends of Ulcerative Colitis in China and Worldwide
Weiqing ZHANG ; Yizhong LIANG ; Meilan MO ; Zhulin WU ; Weijun LUO ; Dong ZHANG ; Derong LIN
Journal of Sun Yat-sen University(Medical Sciences) 2026;47(5):857-867
ObjectiveTo assess changes in the incidence, prevalence, and disability-adjusted life-year (DALY) burden of ulcerative colitis (UC) in China and worldwide from 1990 to 2023 using data from the Global Burden of Disease Study 2023 (GBD 2023), and to examine demographic drivers and future trends. MethodsUC data for China, the world, and 204 countries and territories were extracted from the GBD 2023 Results Tool. Age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), and age-standardized DALY rate (ASDR), with 95% uncertainty interval (UI), were obtained. Joinpoint regression was used to estimate average annual percent change (AAPC) and 95% confidence interval (CI). Spearman rank correlation, inequality and frontier analyses, Das Gupta decomposition, and autoregressive integrated moving average (ARIMA) models were used to assess associations with the sociodemographic index (SDI), cross-country burden disparities, demographic drivers, and trends from 2024 to 2035, respectively. ResultsIn 2023, the ASIR, ASPR, and ASDR in China were 0.94, 5.95, and 5.94 per 100 000 population, respectively, lower than the corresponding global estimates of 2.87, 28.48, and 13.82 per 100 000 population. From 1990 to 2023, China’s ASIR and ASPR increased, with AAPCs of 2.720% (95% CI: 2.133%-3.309%) and 2.261% (95% CI: 1.617%-2.908%), whereas the ASDR decreased (AAPC=-3.056%, 95% CI: -3.449% to -2.662%). Globally, ASIR increased slightly, whereas ASPR and ASDR decreased. In China, the crude incidence, prevalence, and DALY rates peaked at ages 50-54 years, 60-64 years, and ≥95 years, respectively. ASIR and ASPR were positively correlated with SDI (rs=0.5794 and 0.6177, both P<0.001), whereas the correlation between ASDR and SDI was not statistically significant (rs=0.0666, P=0.343). In China, epidemiological change contributed most to increases in incident and prevalent cases, and changes in age-specific rates contributed most to the decline in DALYs; globally, population growth and population aging contributed most to the increase in DALYs. By 2035, China’s ASIR, ASPR, and ASDR were projected to be 1.23, 6.37, and 2.55 per 100 000 population, respectively. ConclusionsFrom 1990 to 2023, the age-standardized incidence and prevalence rates of UC increased in China, whereas the age-standardized DALY rate decreased, and peaks in absolute burden generally shifted toward middle-aged and older age groups. The projected directions may persist. These findings may provide reference for long-term UC management and health-resource planning.
10.The Predictive Value of Dual-layer Spectral Detector CT Parameters on Lymph Node Metastasis of Nonfunctional Pancreatic Neuroendocrine Tumor
Mingjie CHEN ; Ke LI ; Jiadan LUO ; Jiayi YANG ; Huasong CAI ; Shiting FENG ; Yanji LUO ; Siya SHI
Journal of Sun Yat-sen University(Medical Sciences) 2026;47(5):868-879
ObjectiveTo investigate the value of preoperative dual-layer spectral detector CT (DLCT) parameters in predicting lymph node metastasis (LNM) of non-functional pancreatic neuroendocrine neoplasms (NF-pNENs). MethodsA retrospective study was conducted on patients with pathologically confirmed NF-pNENs who underwent preoperative contrast-enhanced DLCT examination between September 2019 and July 2024. Regions of interest (ROIs) were manually delineated on three representative slices of the solid component of the lesion, and the mean values were recorded. Conventional CT parameters, monochromatic energy images (40 keV, 70 keV, 100 keV), iodine concentration maps, and effective atomic number (Zeff) maps in the pancreatic parenchymal phase and portal venous phase were acquired. A total of 34 parameters, including clinical characteristics, imaging features, conventional CT and DLCT quantitative parameters, were analyzed. Intergroup differences were compared between the LNM and non-LNM groups. Independent predictive factors were screened using logistic regression and least absolute shrinkage and selection operator (LASSO) regression. Receiver operating characteristic (ROC) curves were generated for each predictive model, and the area under the curve (AUC) was calculated to evaluate the predictive efficacy. ResultsA total of 82 patients with NF-pNENs were enrolled, including 37 males and 45 females, with a mean age of 49.7±14.7 years. Thirty patients were performed with LNM and 52 were with non-LNM. After univariate logistic regression, LASSO regression and multivariate stepwise logistic regression analyses, body mass index (BMI), organ invasion, normalized CT value in the portal venous phase (nCTv) and normalized iodine concentration in the portal venous phase (nICv) were identified as independent predictive factors. The AUCs of the clinical-radiological qualitative model (BMI+organ invasion), conventional CT model (nCTv), DLCT model (nICv) and comprehensive model (organ invasion+nICv) were 0.815 (0.719, 0.910), 0.750 (0.642, 0.858), 0.829 (0.733, 0.925) and 0.865 (0.879, 0.953), respectively. The comprehensive model combining clinical-radiological and DLCT characteristics exhibited superior predictive performance. ConclusionDLCT parameters are more effective than conventional CT parameters in predicting LNM in NF-pNENs, enabling non-invasive preoperative prediction and assisting clinical decision-making.

Result Analysis
Print
Save
E-mail